Brevia Health deepens vaccines expertise with Nick Lowen appointment

Brevia Health has deepened our vaccines expertise with the appointment of Nick Lowen as an Associate with over 30 years’ life sciences experience including serving as Vice President, Commercial Strategic Projects at GSK.  During his time at GSK, Nick successfully led complex negotiations including the introduction of innovative vaccines for the UK and other European markets.  As Vice Chair of the UK Industry Vaccines Group, he oversaw the development of the ABPI position on market access and response to the DHSC CEMIPP report.  Nick joins our senior team of advisers that include Gillian Leng CBE (former CEO, NICE), Jonathan Mogford (former Director of Policy, MHRA) and Mike Thompson MBE (former CEO, ABPI).

Nick trained as a pharmacist and began his career in the NHS.  Before joining the Biopharma industry, he was one of the UK’s first regional NHS Pharmaceutical advisers.

He joined GSK in 1997 where he worked for over 25 years and held a number of senior leadership roles.  During this period, he successfully led complex negotiations including the introduction of innovative vaccines for the UK and other European markets.  As Vice Chair of the UK Industry Vaccines Group, Nick oversaw the development of the ABPI position on market access and response to the DHSC CEMIPP report.

In addition to Vaccines, Nick has therapeutic experience in Neurology, Dermatology, Anti-infectives, Respiratory, Oncology and specialist medicines.

Nick has a passion for delivering marketing and sales excellence across Global, EU and UK Pharmaceutical markets through launching innovative products, life cycle management and building market access.  He has a strong track record managing teams to create and deliver strategic business change in Pharma, including managing the transition to outsource operations in multiple countries, creating business development opportunities, and negotiating and concluding significant business deals.

 

BREVIA HEALTH PROVIDES STRAIGHTFOWARD PUBLIC AFFAIRS AND PUBLIC RELATIONS SUPPORT TO BUSINESSES AND CHARITIES OPERATING IN THE HIGHLY REGULATED UK HEALTHCARE SECTOR

Discover how Brevia can help you and your organisation by viewing our Health services or contacting the Brevia Team on 020 7091 1650 or emailing us at contact@brevia.co.uk

 

 

 

 

 

LATEST NEWS

Transport

How is accessible transport policy changing in the UK?

24 per cent of the UK population are disabled yet public transport is frequently described as ‘difficult’ and ‘inaccessible’ by disabled passengers. The Government has set out how it aims to improve this, most notably through the Inclusive Transport Strategy (2018) and the National Disability strategy (2021). Below, Brevia analyses the most frequent issues surrounding access in public transportation and the associated political debates and policies.

Read More »
Health

AI and Healthcare: key questions and answers

In an era marked by unprecedented advances in technology, the intersection of AI, healthcare, and life sciences has paved the way for improved medical practice, research, and patient care. From predictive diagnostics to personalized treatment plans, AI is revolutionising how healthcare is delivered and experienced in the UK.

Read More »
  • Get in touch to arrange your free monitoring trial.

  • This field is for validation purposes and should be left unchanged.